Neoleukin Therapeutics
Earnings Surprise
Analysts estimated NGNE earnings of $-1.32 per share this quarter (Q1). NGNE's actual earnings were $-1.39 per share.
NGNE EPS surprise of -5.13%Analysts estimated NGNE earnings of $-1.27 per share this quarter (Q3). NGNE's actual earnings were $-0.99 per share.
NGNE EPS surprise of 22.35%Analysts estimated NGNE earnings of $-1.18 per share this quarter (Q2). NGNE's actual earnings were $-1.05 per share.
NGNE EPS surprise of 11.14%Analysts estimated NGNE earnings of $-1.15 per share this quarter (Q4). NGNE's actual earnings were $-0.99 per share.
NGNE EPS surprise of 14.11%Analysts estimated NGNE earnings of $-1.16 per share this quarter (Q1). NGNE's actual earnings were $-1.00 per share.
NGNE EPS surprise of 13.62%Analysts estimated NGNE earnings of $-1.20 per share this quarter (Q4). NGNE's actual earnings were $-1.51 per share.
NGNE EPS surprise of 26.17%Analysts estimated NGNE earnings of $-0.03 per share this quarter (Q3). NGNE's actual earnings were $-0.41 per share.
NGNE EPS surprise of 1239.87%